We refer to your email dated 2nd May 2026, seeking additional details for the corporate announcement made on 1st May, 2026 pertaining to resignation of Mr. Sachin Mehta as Chief Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sudarshan Pharma Industries has responded to BSE's query regarding Mr. Sachin Mehta's resignation as Chief Financial Officer. The resignation took effect from 1st May 2026. Mr. Mehta had submitted his resignation letter dated 27th April 2026. In the letter, he explicitly states there are no material reasons for his resignation other than what has already been provided. Notably, Mr. Mehta will continue to serve as Joint Managing Director of the company, indicating he is not leaving the organisation entirely but merely stepping down from the CFO role. The company has enclosed the full resignation letter containing detailed reasons.
The resignation of the CFO is a key management change. While the departure appears amicable with Mr. Mehta staying on as Joint Managing Director, investors should monitor for any subsequent appointment of a new CFO and any impact on financial reporting or investor communications.